The platform, which reports serving over 100,000 patients, connects individuals with licensed medical providers through its partnership with OpenLoop Health, a network of U.S.-licensed doctors
Nausea occurs because GLP-1 receptor agonists slow gastric emptying, which can cause a feeling of fullness or queasiness, especially after eating
ColonBroom positions itself as a natural, non-invasive alternative for those who want similar appetite support without medical barriers
The observation that the insulinotropic actions of GLP-1 are reduced in type 2 diabetes mellitus (T2DM) led to the development of incretin-based therapies GLP-1 receptor agonists and dipeptidyl peptidase 4 (DPP-4) inhibitors for the treatment of hyperglycaemia in these patients
The effect is powerful and immediate, which is both its greatest strength and its fundamental limitation
Nearly 50% omitted vital details about side effects, precautions, and warnings